TFRC and Alzheimer disease: Studies in human TfR knockin (TfRmu/hu KI) mice and nonhuman primates (NHPs) confirmed the broad distribution of therapeutic ASOs across brain regions, highlighting the OTV’s potential for treating AD [121].